[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

![yusufhameed Avatar](https://lunarcrush.com/gi/w:24/cr:twitter::47121634.png) Yusuf Hameed, MD [@yusufhameed](/creator/twitter/yusufhameed) on x 1593 followers
Created: 2025-07-18 09:48:02 UTC

That's why I still like @SangamoTx $SGMO. No deaths. 

The three patients died after receiving Sarepta's gene therapies $SRPT using an adeno-associated virus (AAV) vector-based gene therapy approach.

Multiple sources explicitly state that there have been no deaths reported in Sangamo's Phase 1/2 STAAR study of isaralgagene civaparvovec for Fabry disease. In fact, one source highlights that no adverse events led to study discontinuation and there were no deaths. Another source also emphasizes the favorable safety and tolerability profile without the need for preconditioning.


XXXXX engagements

![Engagements Line Chart](https://lunarcrush.com/gi/w:600/p:tweet::1946144927228019176/c:line.svg)

**Related Topics**
[aav](/topic/aav)
[$srpt](/topic/$srpt)
[$sgmo](/topic/$sgmo)
[sarepta therapeutics inc](/topic/sarepta-therapeutics-inc)
[stocks healthcare](/topic/stocks-healthcare)

[Post Link](https://x.com/yusufhameed/status/1946144927228019176)